EMA’s Future Home: Assessment Of Bids Nears Completion Amid Growing Staff Concerns
Executive Summary
Sept. 30 is the date by which the European Commission must complete its assessment of member states’ bids to host the European Medicines Agency after Brexit. The agency has again highlighted the pressures it is under as a result of the relocation, and the situation has worsened after some LGBT staff members expressed concern about their rights in certain potential host countries in eastern Europe.
You may also be interested in...
EMA Boss Rasi Fields Questions Over Selection Process For Agency Home Post-Brexit
A press conference following the announcement that the European Medicines Agency is to move from London to Amsterdam included a series of questions on the selection process and the voting itself.
EMA Paints Nightmare Scenario Of EU System ‘Unraveling’ If Relocation Goes Wrong
The European Medicines Agency says it could lose more than 70% of its staff if it moves to one of the cities least favored by current employees. In the worst-case scenario, the EMA says it would be unable to operate and that the regulatory system would “unravel.”
EMA Argues Pre-Submission Activities Under Ombudsman's Radar Are A Legal Requirement
The European Medicines Agency maintains it is fulfilling a legal obligation by organizing early interaction meetings with drug developers. The regulator is meeting with the EU Ombudsman, who is investigating whether such interactions can influence the agency’s decisions on marketing authorization applications.